D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 56 Citations 13,202 207 World Ranking 2542 National Ranking 90

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Acquired immunodeficiency syndrome

His main research concerns Internal medicine, Immunology, Virology, Viral load and Pneumonia. Andy I. M. Hoepelman focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Diabetes mellitus and, in certain cases, Urinary system, Bacteriuria and Escherichia coli. His research in Immunology is mostly focused on Immunopathology.

His studies in Virology integrate themes in fields like Severe combined immunodeficiency, Hypogammaglobulinemia, Epidemiology and Drug resistance. His research integrates issues of Maraviroc, Ebola virus infection, Vicriviroc, HIV tropism and Hepatitis B virus in his study of Viral load. His Pneumonia research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Surgery, Respiratory tract infections and Colistin.

His most cited work include:

  • Immune dysfunction in patients with diabetes mellitus (DM) (776 citations)
  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. (450 citations)
  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Immunology, Virology, Microbiology and Gastroenterology. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus and Surgery. The study incorporates disciplines such as Urinary system, Asymptomatic bacteriuria and Bacteriuria in addition to Diabetes mellitus.

His work in Surgery covers topics such as Pneumonia which are related to areas like Intensive care medicine. His Immunology research includes elements of Acquired immunodeficiency syndrome, Antiretroviral therapy and Disease. Andy I. M. Hoepelman interconnects Drug resistance and Genotype in the investigation of issues within Virology.

He most often published in these fields:

  • Internal medicine (38.31%)
  • Immunology (29.35%)
  • Virology (15.92%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (38.31%)
  • Coxiella burnetii (4.98%)
  • Q fever (4.48%)

In recent papers he was focusing on the following fields of study:

Andy I. M. Hoepelman spends much of his time researching Internal medicine, Coxiella burnetii, Q fever, Virology and Disease. The Internal medicine study combines topics in areas such as Gastroenterology and MEDLINE. His study on Coxiella burnetii also encompasses disciplines like

  • Serology, which have a strong connection to Titer and Pneumonia,
  • Retrospective cohort study which intersects with area such as Relative risk, Young adult, Men who have sex with men, Chronic infection and Cross-sectional study.

His biological study spans a wide range of topics, including Digital polymerase chain reaction and Disease classification. His research in the fields of Steatohepatitis overlaps with other disciplines such as Grounded theory. As part of the same scientific family, Andy I. M. Hoepelman usually focuses on Hematology, concentrating on Hematopoietic stem cell transplantation and intersecting with Immunology.

Between 2017 and 2021, his most popular works were:

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study (436 citations)
  • Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies. (38 citations)
  • New filovirus disease classification and nomenclature (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Andy I. M. Hoepelman mainly focuses on Internal medicine, Disease, Virus, Virology and Viral hepatitis. His Internal medicine study incorporates themes from Chloroquine and Mononucleosis. His research integrates issues of Cochrane Library, MEDLINE, Molecular diagnostics and Respiratory system in his study of Virus.

His research investigates the connection between Virology and topics such as Amino acid that intersect with issues in Disease burden. He has included themes like Dyslipidemia, Bioinformatics, Fatty liver, Cirrhosis and Insulin resistance in his Viral hepatitis study. His work carried out in the field of Confidence interval brings together such families of science as Odds ratio, Clinical trial, Hydroxychloroquine, Randomized controlled trial and Meta-analysis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Immune dysfunction in patients with diabetes mellitus (DM)

Suzanne E Geerlings;Andy I.M Hoepelman.
Fems Immunology and Medical Microbiology (1999)

1370 Citations

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

L M A J Muller;K J Gorter;Eelko Hak;W L Goudzwaard.
Clinical Infectious Diseases (2005)

1052 Citations

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen.
The Lancet Gastroenterology & Hepatology (2018)

1010 Citations

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg.
Nature Medicine (2005)

642 Citations

Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)

563 Citations

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Gerd Fätkenheuer;Mark Nelson;Adriano Lazzarin;Irina Konourina.
The New England Journal of Medicine (2008)

420 Citations

Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults

Douwe F. Postma;Cornelis H. van Werkhoven;Leontine J.R. van Elden;Steven F.T. Thijsen.
The New England Journal of Medicine (2015)

386 Citations

Clinical Management of Ebola Virus Disease in the United States and Europe.

Timothy M. Uyeki;Aneesh K. Mehta;Richard T. Davey;Allison M. Liddell.
The New England Journal of Medicine (2016)

344 Citations

Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction.

Leontine J.R. Van Elden;Anton M. Van Loon;Floris Van Alphen;Karin A.W. Hendriksen.
The Journal of Infectious Diseases (2004)

268 Citations

CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia

Joris M. van Montfrans;Andy I.M. Hoepelman;Sigrid Otto;Marielle van Gijn.
The Journal of Allergy and Clinical Immunology (2012)

259 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andy I. M. Hoepelman

Marc J. M. Bonten

Marc J. M. Bonten

Utrecht University

Publications: 42

Charles A. Boucher

Charles A. Boucher

Erasmus University Rotterdam

Publications: 34

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 29

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 28

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 27

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 26

Bonaventura Clotet

Bonaventura Clotet

IrsiCaixa

Publications: 26

Anna Maria Geretti

Anna Maria Geretti

University of Liverpool

Publications: 26

Daniel R. Kuritzkes

Daniel R. Kuritzkes

Brigham and Women's Hospital

Publications: 25

Arturo Casadevall

Arturo Casadevall

Johns Hopkins University

Publications: 25

Didier Raoult

Didier Raoult

Aix-Marseille University

Publications: 23

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 23

Jürgen K. Rockstroh

Jürgen K. Rockstroh

University Hospital Bonn

Publications: 23

Yukari C. Manabe

Yukari C. Manabe

Johns Hopkins University School of Medicine

Publications: 22

Rob J. L. Willems

Rob J. L. Willems

Utrecht University

Publications: 22

Chien-Ching Hung

Chien-Ching Hung

National Taiwan University

Publications: 21

Trending Scientists

Guodong Guo

Guodong Guo

Baidu (China)

Ilan Benjamin

Ilan Benjamin

University of California, Santa Cruz

G. N. Patey

G. N. Patey

University of British Columbia

Gregory E. Hilmas

Gregory E. Hilmas

Missouri University of Science and Technology

James R. Spotila

James R. Spotila

Drexel University

Dan Grandér

Dan Grandér

Karolinska Institute

Klaus T. Preissner

Klaus T. Preissner

University of Giessen

Priscille Brodin

Priscille Brodin

University of Lille

Pascale Champagne

Pascale Champagne

Queen's University

Matthew J. Colloff

Matthew J. Colloff

Australian National University

Alan J. Thomas

Alan J. Thomas

Newcastle University

Ruth A. Baer

Ruth A. Baer

University of Kentucky

Brent L. Wood

Brent L. Wood

University of Washington

Janeen Baxter

Janeen Baxter

University of Queensland

Ole R. Holsti

Ole R. Holsti

Duke University

Simon Bulmer

Simon Bulmer

University of Sheffield

Something went wrong. Please try again later.